SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.75-1.8%Nov 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (76)4/5/1997 8:41:00 PM
From: Gerald Thomas   of 455
 
I bought agouron early at 14 and really only doubled it..but that was a while ago..

On the positive side of procept (not that they deserve it)
I believe the sec filing says they are in discussions with the NIH and a comparable agency in britain for complete trial funding (and wouldn't be surprised if they get it) but that's not a company buying an interest just someone to help fund them through the trials...
and I still wan't to know what happened to systemic trial with active ingrediant.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext